Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07248839 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

Name: A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment — clinical trial record (NCT07248839)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhasePhase 1

SponsorBristol-Myers Squibb

Started2025-12-15

View on ClinicalTrials.gov ↗

Amendment history

2026-09-22

Trial completed

Final enrollment: 69 participants (planned 24)

2026-06-10

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Primary completion date2026-04-06→2026-08-05

Completion date2026-04-06→2026-08-05

Study sites0→3

2025-11-18

Original filing

Bristol-Myers Squibb

311 trials monitored

See 15 trials at risk

The purpose of this study is to determine the pharmacokinetic and safety of BMS-986435 in participants with normal hepatic function and participants with different degrees of hepatic impairment

Trial Details

NCT Number	NCT07248839
Lead Sponsor	Bristol-Myers Squibb
Conditions	Healthy Volunteers, Hepatic Impairment
Enrollment	69 participants
Start Date	2025-12-15
Primary Completion	2026-08-20 (estimated)
Study Completion	2026-08-20 (estimated)
Updated on ClinicalTrials.gov	2026-09-21